Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update
16 nov. 2021 09h58 HE
|
Protagenic Therapeutics, Inc.
NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders,...